DICOM PS3.16 2024d - Content Mapping Resource |
---|
HTML | FHIR JSON | FHIR XML | IHE SVS XML
Since this Context Group defines the sites, rather than routes of administration, if the exogenous substance is administered into a tumor, the code for the morphologic abnormality (108369006, SCT, "Tumor") is used, rather than the specific concept for the route (447122006, SCT, "Intratumor route") (which may also be present as the value for the separately encoded route of administration, if present).
DICOM PS3.16 2024d - Content Mapping Resource |
---|